- Home
- KNSA vs CASH Comparison
KNSA vs CASH Comparison
Compare KNSA & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- CASH
- Stock Information
- Founded
- KNSA 2015
- CASH 1954
- Country
- KNSA United Kingdom
- CASH United States
- Employees
- KNSA N/A
- CASH N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- CASH Major Banks
- Sector
- KNSA Health Care
- CASH Finance
- Exchange
- KNSA Nasdaq
- CASH Nasdaq
- Market Cap
- KNSA 1.5B
- CASH 1.7B
- IPO Year
- KNSA 2018
- CASH N/A
- Fundamental
- Price
- KNSA $20.21
- CASH $70.33
- Analyst Decision
- KNSA Strong Buy
- CASH Buy
- Analyst Count
- KNSA 6
- CASH 2
- Target Price
- KNSA $37.17
- CASH $90.50
- AVG Volume (30 Days)
- KNSA 638.0K
- CASH 259.3K
- Earning Date
- KNSA 04-29-2025
- CASH 04-22-2025
- Dividend Yield
- KNSA N/A
- CASH 0.28%
- EPS Growth
- KNSA N/A
- CASH 12.57
- EPS
- KNSA N/A
- CASH 6.88
- Revenue
- KNSA $423,239,000.00
- CASH $719,617,000.00
- Revenue This Year
- KNSA $37.21
- CASH $14.27
- Revenue Next Year
- KNSA $2.58
- CASH $6.20
- P/E Ratio
- KNSA N/A
- CASH $10.22
- Revenue Growth
- KNSA 56.60
- CASH 9.58
- 52 Week Low
- KNSA $16.56
- CASH $48.27
- 52 Week High
- KNSA $28.15
- CASH $86.00
- Technical
- Relative Strength Index (RSI)
- KNSA 44.56
- CASH 46.23
- Support Level
- KNSA $18.26
- CASH $64.60
- Resistance Level
- KNSA $21.24
- CASH $71.72
- Average True Range (ATR)
- KNSA 1.12
- CASH 3.19
- MACD
- KNSA -0.12
- CASH 0.15
- Stochastic Oscillator
- KNSA 44.43
- CASH 52.93
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About CASH Pathward Financial Inc.
Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.